Background Pre‐eclampsia is associated with deficient intravascular production of
prostacyclin, a vasodilator, and excessive production of thromboxane, a vasoconstrictor and …

Objectives: To assess the effectiveness and safety of antiplatelet agents, such as aspirin and
dipyridamole, when given to women at risk of developing pre-eclampsia. Search methods …

Background Pre-eclampsia is associated with deficient intravascular production of
prostacyclin, a vasodilator, and excessive production of thromboxane, a vasoconstrictor and …

Background Pre‐eclampsia is associated with deficient intravascular production of
prostacyclin, a vasodilator, and excessive production of thromboxane, a vasoconstrictor and …

We set out to assess the ability of antiplatelet agents, such as aspirin and dipyridamole, to
prevent women from developing pre-eclampsia during pregnancy and to improve health …

Antiplatelet agents for preventing pre-eclampsia and its complications | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …

Background Pre‐eclampsia is associated with deficient intravascular production of
prostacyclin, a vasodilator, and excessive production of thromboxane, a vasoconstrictor and …

Objectives: To assess the effectiveness and safety of antiplatelet agents, such as aspirin and
dipyridamole, when given to women at risk of developing pre-eclampsia. Search methods …

Background Pre‐eclampsia is associated with deficient intravascular production of
prostacyclin, a vasodilator, and excessive production of thromboxane, a vasoconstrictor and …

Background Pre-eclampsia is associated with deficient intravascular production of
prostacyclin, a vasodilator, and excessive production of thromboxane, a vasoconstrictor and …